Alkermes (NASDAQ: ALKS) reported Q4 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the quarter came in at $280 million versus the consensus estimate of $268.25 million.

GUIDANCE:

Alkermes sees 2021 EPS of $0.37-$0.62, versus the consensus of $0.52. Alkermes sees 2021 revenue of $1-1.17 billion, versus the consensus of $1.12 billion.

For earnings history and earnings-related data on Alkermes (ALKS) click here.